Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range19.850 - 48.400 | Open / Close- / - | Float / Outstanding40.000M / 47.100M |
| Vol / Avg.0 / 494.866K | Mkt Cap2.162B | P/E- | 50d Avg. Price42.740 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float40.000M | EPS-2.260 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-27 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.
Who are Celldex Therapeutics's (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA), Sage Therapeutics (NASDAQ:SAGE) and FibroGen (NASDAQ:FGEN).
What is the target price for Celldex Therapeutics (CLDX) stock?
The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.